Back to Journals » Journal of Pain Research » Volume 7

Fasinumab (REGN475), an antinerve growth factor monoclonal antibody, for the treatment of acute sciatic pain: results of a proof-of-concept study

Total article views   HTML views PDF downloads Totals
18,119 Dovepress* 14,484+ 1,950 16,434
PubMed Central* 3,635 746 4,381
Totals 18,119 2,696 20,815
*Since 22 August 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 0 8

View citations on PubMed Central and Google Scholar